Michaela A. Dinan

Economics, Econometrics and FinanceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.190Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing

UNC Libraries(2020)10.17615/vr6a-dp31

Top 66%

0.190DataRank

Top 66%1 citations

Morris Weinberger, Katherine E. Reeder‐Hayes, Melissa A. Troester, Stacie B. Dusetzina, Michaela A. Dinan +3 more

Papers

Driven by 31 papers — median percentile 34. Top paper: “Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinoma”.

Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinoma

JNCI Cancer Spectrum(2023)10.1093/jncics/pkad036

N/A

0.658DataRank · unranked

13 citations

Jessica B. Long, Sirad Hassan, Stephanie B. Wheeler, Lisa P. Spees, Michael Leapman +5 more

Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer Agents

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.04.010

N/A

0.241DataRank · unranked

4 citations

Michaela A. Dinan, Bradford E. Jackson, Christopher D. Baggett, Lauren E. Wilson, Melissa A. Greiner +9 more

Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinoma

Journal of Geriatric Oncology(2022)10.1016/j.jgo.2021.12.012

N/A

0.208DataRank · unranked

3 citations

Lauren E. Wilson, Melissa A. Greiner, Jessica Pritchard, Tian Zhang, Deborah R. Kaye +5 more

Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.8747

N/A

0.208DataRank · unranked

3 citations

Jessica B. Long, Sarah J. Westvold, Michael Leapman, Lisa P. Spees, Michael E. Hurwitz +5 more

Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing

UNC Libraries(2020)10.17615/vr6a-dp31

Top 66%

0.190DataRank

Top 66%1 citations

Morris Weinberger, Katherine E. Reeder‐Hayes, Melissa A. Troester, Stacie B. Dusetzina, Michaela A. Dinan +3 more

Disparities in utilization of oral anticancer agents and related costs in elderly patients with metastatic renal cell carcinoma in the United States.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.29_suppl.106

N/A

0.104DataRank · unranked

1 citations

Lisa P. Spees, Jessica Pritchard, Melissa A. Greiner, Charles D. Scales, C.D. Baggett +6 more

Cost trends of metastatic renal cell carcinoma therapy: the impact of oral anticancer agents and immunotherapy

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae067

N/A

0.104DataRank · unranked

1 citations

Jessica B. Long, Sarah J. Westvold, Khushi Agnish, Hannah D. McManus, Michael Leapman +6 more

Mediators of racial disparity in the use of prostate MRI.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6554

N/A

0DataRank · unranked

0 citations

Michaela A. Dinan, Saamir Pasha, Samuel L. Washington, Xiaomei Ma, Cary P. Gross +1 more

Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma.

Journal of Clinical Oncology(2021)10.1200/jco.2020.39.28_suppl.87

N/A

0DataRank · unranked

0 citations

Stephanie B. Wheeler, Bradford E. Jackson, Christopher D. Baggett, Lauren E. Wilson, Melissa A. Greiner +9 more

Patient- and provider-level predictors of mortality among patients with metastatic renal cell carcinoma receiving oral anticancer agents.

Journal of Clinical Oncology(2021)10.1200/jco.2020.39.28_suppl.116

N/A

0DataRank · unranked

0 citations

Michaela A. Dinan, Bradford E. Jackson, Christopher D. Baggett, Lauren E. Wilson, Melissa A. Greiner +9 more

Racial and Ethnic Variation in COVID-19 Vaccination Uptake Among Medicare Beneficiaries with Cancer History

Journal of Racial and Ethnic Health Disparities(2022)10.1007/s40615-022-01415-2

N/A

0DataRank · unranked

3 citations

Michaela A. Dinan, Gevorg Tamamyan, LaRon E. Nelson, Sangchoon Jeon, Hermine Poghosyan

Treatment exposure-based risk-stratification for care of survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10056

N/A

0DataRank · unranked

2 citations

Kayla Stratton, Wendy M. Leisenring, Yutaka Yasui, Eric J. Chow, Chaya S. Moskowitz +5 more

Factors associated with the quality of end-of-life care for patients with metastatic renal cell carcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.300

N/A

0DataRank · unranked

0 citations

Lauren E. Wilson, Bradford E. Jackson, Lisa P. Spees, Christopher D. Baggett, Melissa A. Greiner +10 more

Managing Chronic Pain in Cancer Survivorship: Communication Challenges and Opportunities as Described by Cancer Survivors

American Journal of Hospice and Palliative Medicine®(2023)10.1177/10499091231164634

N/A

0DataRank · unranked

22 citations

Laura J. Fish, Christina Makarushka, Tamara J. Somers, Katie Fitzgerald Jones, Jessica S. Merlin +4 more

Trends in new and persistent opioid use in older adults with and without cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad206

N/A

0DataRank · unranked

11 citations

Madhav KC, Pamela R. Soulos, Molly M. Jeffery, Kathryn J. Ruddy, Catherine C. Lerro +9 more

Total and treatment-related costs of care associated with in patients with metastatic renal cell carcinoma receiving targeted or immune therapy.

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.28

N/A

0DataRank · unranked

2 citations

Jessica B. Long, Sarah J. Westvold, Stephanie B. Wheeler, Lisa P. Spees, Michael Leapman +5 more

Evolution of systemic therapy from 2015 to 2019 for older patients in the United States with metastatic renal cell carcinoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.610

N/A

0DataRank · unranked

0 citations

Jessica B. Long, Sirad Hassan, Stephanie B. Wheeler, Lisa P. Spees, Michael Leapman +5 more

Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma

UNC Libraries(2023)10.17615/p7ah-hs63

N/A

0DataRank · unranked

0 citations

Charles D. Scales, Michaela A. Dinan, Cary P. Gross, Daniel J. George, T. Zhang +9 more

Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United States

UNC Libraries(2023)10.17615/wdxk-b083

N/A

0DataRank · unranked

0 citations

Daniel J. George, T. Zhang, Melissa A. Greiner, Jessica Pritchard, Michaela A. Dinan +6 more

Oral Anticancer Agent (OAA) Adherence and Survival in Elderly Patients With Metastatic Renal Cell Carcinoma (mRCC)

Carolina Digital Repository (University of North Carolina at Chapel Hill)(2023)10.17615/rx12-6w51

N/A

0DataRank · unranked

0 citations

Melissa A. Greiner, Daniel J. George, Charles D. Scales, Cary P. Gross, Lauren E. Wilson +8 more

ONCOLOGISTS’ BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY

UNC Libraries(2024)10.17615/43j9-kj32

N/A

0DataRank · unranked

1 citations

Michaela A. Dinan, Katherine E. Reeder‐Hayes, Stacie B. Dusetzina, Morris Weinberger, Megan C. Roberts +2 more

ACO leakage among gynecologic cancer patients: Incidence, predictors, and impact on annual Medicare expenditure

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.05.020

N/A

0DataRank · unranked

0 citations

Melissa A. Greiner, Brystana G. Kaufman, L Guevara, Michaela A. Dinan, Laura J. Havrilesky +2 more

Off-Label Use of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer(2025)10.1016/j.clgc.2025.102330

N/A

0DataRank · unranked

0 citations

Jessica B. Long, Sarah J. Westvold, Michael Leapman, Michael E. Hurwitz, Aaron Philip Mitchell +4 more

Use of targeted therapy in patients with advanced non-small cell lung cancer in response to broad genomic profiling.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.11155

N/A

0DataRank · unranked

0 citations

Jessica B. Long, John Rothen, Sida Huang, Pamela R. Soulos, Timothy J. Robinson +9 more

Personalized risk assessment of frailty in long-term cancer survivors

Journal of Geriatric Oncology(2026)10.1016/j.jgo.2025.102804

N/A

0DataRank · unranked

0 citations

Sarah J. Westvold, Jessica B. Long, Jane Fan, Terry Hyslop, Kerry Conlin +14 more

Patient-Centered Communication for Discussing Oncotype DX Testing

UNC Libraries(2020)10.17615/486t-8r03

N/A

0DataRank · unranked

0 citations

Megan C. Roberts, Michaela A. Dinan, Stacie B. Dusetzina, Katherine E. Reeder‐Hayes, Amy Bryson +2 more

Adoption of New Risk Stratification Technologies Within US Hospital Referral Regions and Association With Prostate Cancer Management

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.28646

N/A

0DataRank · unranked

28 citations

Rong Wang, Henry S. Park, James B. Yu, Preston C. Sprenkle, Michaela A. Dinan +3 more

Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United States

Kidney Cancer(2021)10.3233/kca-210119

N/A

0DataRank · unranked

9 citations

Lisa P. Spees, Jessica Pritchard, Melissa A. Greiner, Charles D. Scales, Christopher D. Baggett +6 more

Provider‐ and patient‐level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma

Cancer Medicine(2021)10.1002/cam4.4201

N/A

0DataRank · unranked

4 citations

Stephanie B. Wheeler, Bradford E. Jackson, Christopher D. Baggett, Lauren E. Wilson, Melissa A. Greiner +9 more

Oral anticancer agent (OAA) adherence and survival in elderly patients with metastatic renal cell carcinoma (mRCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.280

N/A

0DataRank · unranked

1 citations

Lauren E. Wilson, Melissa A. Greiner, Lisa P. Spees, Jessica Pritchard, Tian Zhang +5 more

Patterns and predictors of oral anticancer agent utilization in diverse metastatic renal cell carcinoma patients.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.279

N/A

0DataRank · unranked

0 citations

Lisa P. Spees, Bradford E. Jackson, Christopher D. Baggett, Lauren E. Wilson, Melissa A. Greiner +5 more

Michaela A. Dinan

Indexed papers

Top data-sharing exemplar

Papers